“In Oregon, marijuana is second only to alcohol when it comes to admissions for substance abuse treatment, yet it’s hard to find any targeted programs here or elsewhere,” reports Portland Business Journal writer Elizabeth Hayes. She goes on to describe a study being carried out by CODA Research that is looking at the effects of the drug N-acetylcysteine, or NAC, on marijuana-use abstinence.
More News
Study finds tapering, clinic policies can reduce opioid use
(UPDATE: Coverage on Sen. Jeff Merkley’s website too.) Medical Press and Partnership For Drug-Free Kids, and other websites are reporting on a study on opioid addiction in which CODA Medical Director Melissa Weimer and …
1/28/2016
CODA Welcomes Newest Board Member Terri Theisen
We are delighted to announce the election of our newest board member Terri Theisen, Principal Consultant at Portland’s T2 Group. Terri worked with CODA several years ago to help raise funds for two large remodeling …
1/5/2021